Status:
ACTIVE_NOT_RECRUITING
Automatic PredICtion of Edema After Stroke
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Stroke, Acute
Brain Edema
Eligibility:
All Genders
Brief Summary
To use machine learning for early detection of malignant brain edema in patients with MCA ischemia
Detailed Description
Malignant cerebral edema following large ischemic strokes account for up to 10% of all ischemic strokes. Mortality rates are high and most of the survivors are left severely disabled. Although decompr...
Eligibility Criteria
Inclusion
- Acute ≥ subtotal MCA infarct (M1-M2 occlusion)
- with or without malignant brain swelling
- with or without reperfusion therapy
- with or without neurosurgical decompression
- with or without death following malignant brain edema
Exclusion
- Non-acute MCA infarct
- \< subtotal MCA infarct
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
1687 Patients enrolled
Trial Details
Trial ID
NCT04057690
Start Date
April 1 2019
End Date
December 31 2025
Last Update
September 10 2025
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
St. John's Hospital
Vienna, Austria
2
Charité Universitätsmedizin Berlin
Berlin, Germany
3
Universitätsklinikum Bonn
Bonn, Germany
4
Fraunhofer- Gesellschaft zur Förderung der angewandten Forschung e.V., Fraunhofer MEVIS
Bremen, Germany